Jupiter Wellness, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Jupiter Wellness, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Jupiter Wellness, Inc. has published 24 public disclosures. The latest transaction was disclosed on 6 September 2023 (Acquisition). Among the most active insiders: MCKINNON DOUGLAS O. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 September 2023
All Executives24 Thresholds0 Prospectus0 Other0
Declarations 24 total
▲ Director · Executives · 31 Aug 2023
1,666,666 shares Common stock SEC:0001493152-23-031845:0
Canonical exit: 29 Nov 2023 (T+90) ▲ Director · Executives · 7 Aug 2023
3,000 shares Common stock SEC:0001493152-23-027288:0
Canonical exit: 5 Nov 2023 (T+90) ● CFO · Executives · 25 Jul 2022
14,124 shares Common Stock SEC:0001493152-23-001305:0
● CEO · Executives · 26 Jul 2022
18,832 shares Common Stock SEC:0001493152-22-037194:0
● CSO, Chairman · Executives · 26 Jul 2022
14,124 shares Common Stock SEC:0001493152-22-037199:0
▲ Director · Executives · 25 Oct 2022
64,060 shares @ US$0.90 54.4% of flow Common Stock SEC:0001493152-22-037192:0
Canonical exit: 23 Jan 2023 (T+90) ● CFO · Executives · 25 Jul 2022
14,124 shares Common Stock SEC:0001493152-22-037193:0
▲ Director · Executives · 20 Oct 2022
57,839 shares @ US$0.8199 45.6% of flow Common Stock SEC:0001493152-22-030112:0
Canonical exit: 18 Jan 2023 (T+90) ● CCO · Executives · 26 Jul 2022
9,416 shares Common Stock SEC:0001493152-22-020448:0
● CSO, Chairman · Executives · 26 Jul 2022
14,124 shares Common Stock SEC:0001493152-22-020452:0
● Chief Financial Officer · Executives · 25 Jul 2022
14,124 shares Common Stock SEC:0001493152-22-020450:0
● CEO · Executives · 26 Jul 2022
18,832 shares Common Stock SEC:0001493152-22-020451:0
◆ CSO, Chairman · Executives · 10 Nov 2021
200,000 shares 0Common Stock SEC:0001493152-21-028643:0
◆ Chief Financial Officer · Executives · 10 Nov 2021
100,000 shares 0Common Stock SEC:0001493152-21-028644:0
▲ CEO, Director · Executives · 5 Oct 2021
1,556 shares @ US$1.30 0.3% of flow Common Stock SEC:0001493152-21-024885:0
Canonical exit: 3 Jan 2022 (T+90) ◆ Chief Financial Officer · Executives · 16 Aug 2021
14,124 shares 0Common Stock SEC:0001493152-21-020608:0
◆ CSO, Chairman · Executives · 16 Aug 2021
14,124 shares 0Common Stock SEC:0001493152-21-020610:0
◆ CEO, Director · Executives · 16 Aug 2021
18,832 shares 0Common Stock SEC:0001493152-21-020606:0
◆ CCO, Director · Executives · 16 Aug 2021
9,416 shares 0Common Stock SEC:0001493152-21-020612:0
▼ Chief Science Officer · Executives · 26 Jul 2021
50,000 shares @ US$2.79 100.0% of flow Common Stock SEC:0001493152-21-017896:0
▼ Chief Financial Officer · Executives · 26 Jul 2021
75,000 shares @ US$2.79 100.0% of flow Common Stock SEC:0001493152-21-017898:0
▼ Chief Executive Officer · Executives · 26 Jul 2021
250,000 shares @ US$2.79 99.7% of flow Common Stock SEC:0001493152-21-017894:0
▼ Chief Compliance Officer · Executives · 26 Jul 2021
150,000 shares @ US$2.79 100.0% of flow Common Stock SEC:0001493152-21-017900:0
▼ Chief Operating Officer · Executives · 26 Jul 2021
15,884 shares @ US$2.79 100.0% of flow Common Stock SEC:0001493152-21-017902:0
关于 Jupiter Wellness, Inc. Jupiter Wellness, Inc.是一家在美国纳斯达克上市的美国公司。该公司于2018年在特拉华州注册成立,最初专注于基于CBD的健康和护肤产品,后来重新定位为更广泛的皮肤病学和消费者健康平台。其主要运营地点位于佛罗里达州朱庇特,这使其拥有明确的美国本土足迹,尽管它围绕局部健康和皮肤健康应用推广产品并发展品牌。([sec.gov](https://www.sec.gov/Archives/edgar/data/1760903/000149315222008220/form10-k.htm?utm_source=openai))
从业务角度来看,Jupiter Wellness一直围绕皮肤、头发和性健康产品的开发、制造和商业化以及选定的治疗项目进行组织。美国证券交易委员会的披露文件描述了一个产品线,其中包括用于湿疹、皮炎、光化性角化病、唇疱疹症状和烧伤相关护理的局部概念,以及消费者健康产品。该公司还提到了专有的非处方药品牌,包括通过其电子商务渠道分销的防晒霜和其他健康产品。([sec.gov](https://www.sec.gov/Archives/edgar/data/1760903/000149315223010480/form10-k.htm?utm_source=openai))
在竞争方面,Jupiter Wellness在一个高度分散的领域运营,产品差异化取决于配方质量、科学可信度、监管执行和市场推广效率。该公司将其战略描述为科学和研究驱动,旨在超越商品化的CBD叙事,在局部治疗和健康领域建立更具防御性的产品组合。尽管如此,它仍然是一个小盘股、处于发展阶段的公司,而非成熟的大盘医疗保健特许经营企业,因此其市场地位应被视为机会主义和高风险,其上涨空间与产品采用和商业化进展相关。([nasdaq.com](https://www.nasdaq.com/press-release/it-all-comes-down-to-science-and-research-with-the-efficacy-of-jupiter-wellnesss?utm_source=openai))
近期发展包括战略重新定位、融资和其他与资产负债表相关的行动,包括2023年披露的PIPE交易。最近提交的美国证券交易委员会文件还强调了持续经营风险,这是股权投资者评估流动性、稀释风险和执行不确定性的一个关键考虑因素。对于关注内部人交易活动的投资者而言,Form 4文件可以提供有用的信号,但在Jupiter Wellness的案例中,应在公司仍处于转型式发展阶段的背景下解读这些文件。([sec.gov](https://www.sec.gov/Archives/edgar/data/1760903/000149315223010480/form10-k.htm?utm_source=openai))